Screening mammograms with or without AI assistance for breast cancer detection
Official title: A Randomized Controlled Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
Run by Jonsson Comprehensive Cancer Center · NCT06934239 · Data updated 2026-11-12
This trial will try using an FDA-cleared AI tool to help radiologists read screening mammograms for adults to see if it finds more cancers and reduces unnecessary callbacks.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 400000 (estimated) |
| Sponsor | Jonsson Comprehensive Cancer Center Academic / other |
| Locations | 6 sites (Los Angeles, California and 5 other locations) |
| Status | Recruiting |
| Started | October 15, 2025 |
| Main results expected | March 1, 2028 |
| Study ends | March 1, 2030 |
| Registry record updated | November 9, 2026 |
| Trial ID | NCT06934239 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who receive routine screening mammograms at one of the participating breast imaging facilities (and the radiologists who interpret those exams) are eligible to participate.
✕Probably not a fit
People who are getting diagnostic (not screening) mammograms, who are screened outside the participating sites, or who have opted out of research will not be included and therefore will not directly benefit from this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In a multisite, real-world randomized trial, individual screening mammography exams are randomly assigned to be interpreted with the AI decision-support tool turned on or off at the exam level. Randomization occurs automatically shortly after image acquisition so radiologists cannot sort exams by AI availability, and patients returning in year two may be re-randomized. The design captures many interpretations with and without AI for each radiologist, allowing measurement of both population-level effects on cancer detection and recall rates and a radiologist-level learning curve. Participating sites include six regional U.S. health systems and all adult screening mammograms at those facilities during the trial period are included unless a patient has opted out of research.
Why it matters
Potential benefit: If successful, the AI tool could help detect more cancers earlier and reduce unnecessary follow-up imaging and recalls.
How similar studies have gone: Prior research and some FDA-cleared AI tools have shown promise for improving cancer detection and altering recall rates, but large multicenter, exam-level randomized trials in real-world U.S. settings remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
This trial will include all radiologists interpreting screening mammography and all adult patients undergoing screening mammography at any of the participating breast imaging facilities across 6 regional health systems (UCLA, UC San Diego, University of Washington-Seattle, University of Wisconsin-Madison, Boston Medical Center, and University of Miami) during the trial period. Individuals must meet the following eligiblity criteria. Inclusion Criteria: 1. Be at least 18 years of age or older 2. Receive a screening mammogram at one of the participating breast imaging facilities OR be a radiologist who interprets screening mammograms at one of the participating breast imaging facilities. Exclusion Criteria: 1\. Patients who have opted out of all research at the health system
Where it's running
-
University of California Los Angeles Health System
Los Angeles, California, United States Recruiting -
University of California, San Diego
San Diego, California, United States Recruiting -
University of Miami Health System
Miami, Florida, United States Recruiting -
Boston Medical Center
Boston, Massachusetts, United States Recruiting -
University of Washington Health System
Seattle, Washington, United States Recruiting -
University of Wisconsin-Madison
Madison, Wisconsin, United States Recruiting
Study contacts
- Principal investigator: Joann G Elmore, MD, MPH — University of California, Los Angeles
- Study coordinator: Michelle L'Hommedieu, PhD
- Email: mlhommedieu@mednet.ucla.edu
- Phone: (310) 592-9454
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Single radiologist with AI support versus two radiologists for screening mammograms
This trial will see if one radiologist aided by AI can match the performance of the usual two-radiologist reading for screening mammograms in women aged 45–69.
-
AI-assisted whole-course management for safe medicine use in advanced solid tumors
A real-world study compares a smartphone-based digital management system with usual care to see if it reduces drug-related problems and healthcare needs for adults with advanced solid tumors receiving cancer therapy.
-
AI-assisted and traditional workflows for admission diagnosis and management planning
This trial tests whether an AI-agent workflow helps doctors make better admission diagnoses and care plans on simulated cases, compared with plain AI-assisted and traditional workflows.
-
Prediction score for death or lung transplant in emphysema caused by alpha-1 antitrypsin deficiency
This study tests a new prediction tool to identify people with emphysema due to alpha-1-antitrypsin deficiency who are at high risk of death or needing a lung transplant.
-
Timing of AI Help in Chest X-Rays: Does When AI Becomes Visible Change How Clinicians Read Images?
Doctors test chest X-ray interpretation with AI information shown either before or after they start reviewing the image to see how timing affects their search patterns and decisions.
-
Does AI-based cephalometric tracing match digital manual tracing for orthodontic measurements?
This study tests whether AI-powered cephalometric analysis can produce measurements similar to traditional digital tracing in 100 patient radiographs.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.